Busy Minds For Better Brain Health: An Interview With Kristina Lubofsky, Founder of The Busy Minds Box
February 22, 2023
According to the Alzheimer’s Association, more than 6 million Americans currently have Alzheimer’s Disease, with that number projected to rise to nearly 13 million by 2050. For people with Alzheimer’s or other types of cognitive impairment, and for those who care for them, the challenge is to stay active and…
Hope In A Bottle: Leqembi, The Newly Approved Alzheimer’s Medication
January 11, 2023
As a follow-up to our previous article portending the next new drug for Alzheimer’s, the FDA has now given approval under its accelerated approval pathway to the new medication Leqembi (originally known as Lecanemab). This drug was developed to help slow down cognitive decline in those with Mild Cognitive Impairment…
Play On Words: Crossword Puzzles For Brain Protection
November 9, 2022
The evidence goes back and forth but the intuition feels right: Engaging your brain with word puzzles, riddles, problem-solving scenarios, or even computer games seems like it should sharpen your mind, support your memory, or strengthen your cognitive abilities. Well, new evidence just published in the New England Journal of…
Car Talk: Should You Be Driving In Your Later Years?
November 2, 2022
We’ve never shied away from the difficult discussion of whether and when older adults should hand over their keys and stop driving their cars. Clearly, there’s no one specific age at which older adults must stop driving- and to assume a senior will inevitably need to stop would be an…
Mind Boggling: Dementia Diagnoses & Evolving Demographic Trends
October 26, 2022
We all know that as a society, our population is getting older and living longer than previous generations. And while that’s a wonderful trend if you are able to get more years of good health and quality living, the flipside of that is many of us will face, either for…
Next Up: Another (More Promising?) New Drug For Alzheimer’s
October 5, 2022
You may remember that more than a year ago, we posted a story on the arrival of a new drug approved by the FDA for the treatment of Alzheimer’s disease. That drug is Aduhelm, and while it is technically on the market and available, its use has been greatly limited…